A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...

A biology teacher and mother-of-two has become the first patient in the UK to receive a “gamechanger” therapy to treat ...

Emily Henders received her CAR T last week at University College London Hospital (UCLH) as part of a global clinical trial ...

Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...

A biology teacher from Bushey has become the first patient in the UK to receive a “gamechanger” therapy to treat multiple ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of fenebrutinib, and bone marrow transplantation as an effective long-term treatment.

Women with multiple sclerosis, particularly after menopause, experience a higher risk of relapse-independent worsening, whereas men have a greater worsening of disability with every event.

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...